market took a whack towards the end of the session.
I was very excited to listen to Silvu and co, and analysts seemed positive on the announcement too. 60% reduction in mortality and significant reductions in heart attacks and strokes is very promising! I am more confident we can get accelerated approval on this based on these results as a double blinded placebo controlled trial (and one of, if not, the biggest cellular medicine trial ever?) and a commercial partner is probably closer than we anticipated... I am personally punting on Novartis again but time will tell. gltah.
MSB Trading 2020 - a new dawn, page-12175
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |